Results 1 to 10 of about 312,772 (298)

Alternatives to Subcutaneous Immunotherapy for Allergic Rhinitis [PDF]

Allergies, 2022
Allergic rhinitis (AR) is an important public health issue worldwide due to its increasing prevalence and impact on quality of life, school performance, and work productivity.
Tetsuya Terada, Ryo Kawata
exaly   +4 more sources

Subcutaneous immunotherapy in a patient taking ofatumumab for multiple sclerosis and upadacitinib for atopic dermatitis [PDF]

Journal of Allergy and Clinical Immunology: Global
Allergen-specific immunotherapy has not been well-studied in the setting of increasingly common immune system-targeting medications. Subcutaneous immunotherapy may not be contraindicated in patients taking anti-CD20 mAbs antibodies and/or Janus kinase ...
Twan Sia, BA, Leeon Bacchus, BA, Stanley Liu, BS, John Leung, MD   +3 more
doaj   +3 more sources

Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children [PDF]

Frontiers in Pediatrics, 2017
This review presents up-to-date understanding of immunotherapy in the treatment of children with allergic asthma. The principal types of allergen immunotherapy (AIT) are subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT).
Sophia Tsabouri, Gavriela Feketea, George V Guibas   +2 more
exaly   +4 more sources

The Evaluation of Local and Systemic Reactions to Subcutaneous House Dust Mite Allergen Immunotherapy

Trends in Pediatrics, 2022
Objective: Allergen-specific immunotherapy is an effective treatment method that enables the development of immunotolerance against allergens in allergic rhinitis, asthma, and venom allergy.
Zuhal Karalı, Şükrü Çekiç, Yağmur Hazal Şadırvan, Yakup Canıtez, Nihat Sapan   +4 more
doaj   +2 more sources

Nicolau syndrome: A case of ischemic necrosis after subcutaneous immunotherapy [PDF]

Journal of Allergy and Clinical Immunology: Global
A rare injection site reaction known as Nicolau syndrome can occur in patients receiving subcutaneous immunotherapy. This syndrome has been reported only a handful of times in the literature related to subcutaneous immunotherapy.
Joyce Kim, MD, Tim Kaddis, MD, Spencer Boyle, MD, Sandeep Gupta, MD, Vivian Wang, MD, Joseph Yusin, MD   +5 more
doaj   +2 more sources

Evaluation of the Correlation Between Nasal Secretion ECP-MPO Test Papers and Immune Markers in Subcutaneous Immunotherapy of Dust Mites [PDF]

Journal of Asthma and Allergy
Yang Xi,1,* Yu-Qin Deng,1,2,* Han-Da Li,1 Wo-Er Jiao,1 Jin Chen,2 Jian-Jun Chen,3 Ze-Zhang Tao1,2 1Department of Otolaryngology, Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, People’s Republic of China; 2Institute of ...
Xi Y, Deng YQ, Li HD, Jiao WE, Chen J, Chen JJ, Tao ZZ   +6 more
doaj   +2 more sources

Dose dependence of efficacy and safety of subcutaneous immunotherapy

Monaldi Archives for Chest Disease, 2016
A number of experimental and clinical evidence has shown that exposure to high amounts of allergen molecules favours the development of tolerance. This is true also for subcutaneous immunotherapy (SCIT), for which a dose dependence of clinical efficacy ...
C. Incorvaia, F. Frati, P. Puccinelli, G.G. Riario-Sforza, S. Dal Bo   +4 more
doaj   +4 more sources

Modelling the Costs of Sublingual Immunotherapy versus Subcutaneous Immunotherapy Based on Clinical Appointments and Impacts of Patient Travel in Sweden [PDF]

ClinicoEconomics and Outcomes Research
Lars-Olaf Cardell,1,2,* Thomas Sterner,3,* Waqas Ahmed,4 Andreas Kallsoy Slættanes,5 Mikael Svärd,6 Richard F Pollock4 1Division of ENT Diseases, Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden;
Cardell LO, Sterner T, Ahmed W, Slættanes AK, Svärd M, Pollock RF   +5 more
doaj   +2 more sources

Prediction of clinical efficacy of subcutaneous immunotherapy for Artemisia sieversiana pollen allergic rhinitis by serum metabolomics

Journal of the Formosan Medical Association, 2022
Background/Purpose: Specific immunotherapy is the only effective etiological treatment for allergic rhinitis, but subcutaneous immunotherapy has a slow onset and poor compliance.
Rui-Li Yu, Chen Pan, Ting-Ting Ma, Xiao-Yan Wang, Hai-Yun Shi, Yan Zhuang, Wei-Jun Yan, Jian-Guo Liu, Meng-Da Cao, Jin-Lyu Sun, De-Yun Wang, Jin-Shu Yin, Ji-Fu Wei, Xue-Yan Wang   +13 more
doaj   +1 more source

Association of allergen sensitization patterns with clinical outcome of subcutaneous allergen-specific immunotherapy in polysensitized allergic patients

Egyptian Journal of Chest Disease and Tuberculosis, 2022
Introduction Understanding sensitization patterns helps clinicians tailor care more effectively. Most clinical studies with positive results used single allergens, but many patients are sensitized to multiple allergens.
Heba W Abdelwahab, Amina Abd El-Maksoud, Nesrine S Farrag, Ahmed M Fouda, Ahmed Ehab   +4 more
doaj   +1 more source